Core Viewpoint - The Guangzhou Municipal Government Office has released a plan to accelerate the construction of an advanced manufacturing city, focusing on high-value-added medical devices and aiming to establish a leading biopharmaceutical and high-end medical device industry hub by 2035 [1] Group 1: Industry Focus - The plan emphasizes the development of in vitro diagnostic instruments, cardiovascular and cerebrovascular diagnostic devices, imaging diagnostic and therapeutic equipment, orthopedic devices, and new materials for ophthalmology and orthopedics [1] - It aims to promote the research and development of medical imaging equipment, medical robots, new implantable devices, home medical monitoring and health equipment, wearable devices, suitable diagnostic equipment for grassroots healthcare, and mobile medical products [1] Group 2: Industry Goals - By 2035, the industry scale is expected to reach 500 billion [1] - The plan outlines the enhancement of industrial foundational research capabilities and the establishment of a more complete industrial chain [1]

Core Insights - Shenhe Reform and Innovation Demonstration Zone has achieved a significant milestone with the approval of Shenyang Pengyue Technology Co., Ltd.'s cardiac cryoablation device and disposable sterile cryoablation probe by the National Medical Products Administration, marking a breakthrough in domestic medical devices for cardiac atrial fibrillation treatment [1][2] Group 1: Product Overview - The cardiac cryoablation device is the core of a complete cryoablation system solution, responsible for precise control of refrigerant delivery and recovery, ensuring stability and safety during the ablation process [2] - The disposable sterile cryoablation probe is a key instrument that directly targets the myocardial area, made from special alloy materials, allowing for full-path cardiac ablation treatment with a single probe, significantly reducing treatment costs [2] Group 2: Technological Advancements - The device has achieved domestic technological breakthroughs in refrigerant selection, active rewarming design, probe vacuum insulation, and flexible structure, with its backside temperature feedback technology being an international first [2] - These advancements are expected to disrupt the long-standing dominance of foreign products in the relevant medical field, providing better treatment options for domestic clinicians and patients [2]